001     128696
005     20240228145547.0
024 7 _ |a 10.1038/leu.2017.55
|2 doi
024 7 _ |a pmid:28196983
|2 pmid
024 7 _ |a 0887-6924
|2 ISSN
024 7 _ |a 1476-5551
|2 ISSN
024 7 _ |a altmetric:20916860
|2 altmetric
037 _ _ |a DKFZ-2017-04711
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Ratnaparkhe, Manasi
|0 P:(DE-He78)e33bb25d8c2a056ddfc1621563fc5c70
|b 0
|e First author
|u dkfz
245 _ _ |a Genomic profiling of Acute lymphoblastic leukemia in ataxia telangiectasia patients reveals tight link between ATM mutations and chromothripsis.
260 _ _ |a Basingstoke
|c 2017
|b Nature Publ. Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1662553189_14975
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Recent developments in sequencing technologies led to the discovery of a novel form of genomic instability, termed chromothripsis. This catastrophic genomic event, involved in tumorigenesis, is characterized by tens to hundreds of simultaneously acquired locally clustered rearrangements on one chromosome. We hypothesized that leukemias developing in individuals with Ataxia Telangiectasia, who are born with two mutated copies of the ATM gene, an essential guardian of genome stability, would show a higher prevalence of chromothripsis due to the associated defect in DNA double-strand break repair. Using whole-genome sequencing, fluorescence in situ hybridization and RNA sequencing, we characterized the genomic landscape of Acute Lymphoblastic Leukemia (ALL) arising in patients with Ataxia Telangiectasia. We detected a high frequency of chromothriptic events in these tumors, specifically on acrocentric chromosomes, as compared with tumors from individuals with other types of DNA repair syndromes (27 cases total, 10 with Ataxia Telangiectasia). Our data suggest that the genomic landscape of Ataxia Telangiectasia ALL is clearly distinct from that of sporadic ALL. Mechanistically, short telomeres and compromised DNA damage response in cells of Ataxia Telangiectasia patients may be linked with frequent chromothripsis. Furthermore, we show that ATM loss is associated with increased chromothripsis prevalence in additional tumor entities.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Hlevnjak, M.
|0 P:(DE-He78)aa1da4918a48503d125ee3325c7f135e
|b 1
|u dkfz
700 1 _ |a Kolb, T.
|0 P:(DE-He78)ff4b82323a90d759d3c7eef0fd8ddfe3
|b 2
|u dkfz
700 1 _ |a Jauch, A.
|b 3
700 1 _ |a Maass, Kendra
|0 P:(DE-He78)5100059e746b377e2e0a37c0e24f6bf7
|b 4
|u dkfz
700 1 _ |a Devens, F.
|0 P:(DE-He78)83cd6bd6ea17b47e625c371d6415bdea
|b 5
|u dkfz
700 1 _ |a Rode, A.
|0 P:(DE-He78)589c214eab93a46a3c170485420edfcb
|b 6
|u dkfz
700 1 _ |a Hovestadt, V.
|0 P:(DE-He78)744146d3b5a3df1e0ac555e5bf1ee5cc
|b 7
|u dkfz
700 1 _ |a Korshunov, A.
|0 P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93
|b 8
|u dkfz
700 1 _ |a Pastorczak, A.
|b 9
700 1 _ |a Mlynarski, W.
|b 10
700 1 _ |a Sungalee, S.
|b 11
700 1 _ |a Korbel, J.
|b 12
700 1 _ |a Hoell, J.
|b 13
700 1 _ |a Fischer, U.
|b 14
700 1 _ |a Milde, T.
|0 P:(DE-He78)0be2f86573954f87e97f8a4dbb05cb0f
|b 15
|u dkfz
700 1 _ |a Kramm, C.
|b 16
700 1 _ |a Nathrath, M.
|b 17
700 1 _ |a Chrzanowska, K.
|b 18
700 1 _ |a Tausch, E.
|b 19
700 1 _ |a Takagi, M.
|0 0000-0002-7580-9184
|b 20
700 1 _ |a Taga, T.
|b 21
700 1 _ |a Constantini, S.
|b 22
700 1 _ |a Loeffen, J.
|b 23
700 1 _ |a Meijerink, J.
|b 24
700 1 _ |a Zielen, S.
|b 25
700 1 _ |a Gohring, G.
|b 26
700 1 _ |a Schlegelberger, B.
|b 27
700 1 _ |a Maass, E.
|b 28
700 1 _ |a Siebert, R.
|b 29
700 1 _ |a Kunz, J.
|b 30
700 1 _ |a Kulozik, A. E.
|b 31
700 1 _ |a Worst, B.
|0 P:(DE-He78)fae1bf941c5fd76cf5356ecfa1243cc4
|b 32
|u dkfz
700 1 _ |a Jones, David
|0 P:(DE-He78)551bb92841f634070997aa168d818492
|b 33
|u dkfz
700 1 _ |a Pfister, Stefan
|0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
|b 34
|u dkfz
700 1 _ |a Zapatka, M.
|0 0000-0001-8287-5967
|b 35
700 1 _ |a Lichter, P.
|0 P:(DE-He78)e13b4363c5fe858044ef8a39c02c870c
|b 36
|u dkfz
700 1 _ |a Ernst, Aurélie
|0 P:(DE-He78)509fb81813c1911954da583129e8ea57
|b 37
|e Last author
|u dkfz
773 _ _ |a 10.1038/leu.2017.55
|g Vol. 31, no. 10, p. 2048 - 2056
|0 PERI:(DE-600)2008023-2
|n 10
|p 2048 - 2056
|t Leukemia
|v 31
|y 2017
|x 1476-5551
909 C O |p VDB
|o oai:inrepo02.dkfz.de:128696
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)e33bb25d8c2a056ddfc1621563fc5c70
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)aa1da4918a48503d125ee3325c7f135e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)ff4b82323a90d759d3c7eef0fd8ddfe3
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)5100059e746b377e2e0a37c0e24f6bf7
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)83cd6bd6ea17b47e625c371d6415bdea
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)589c214eab93a46a3c170485420edfcb
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)744146d3b5a3df1e0ac555e5bf1ee5cc
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)0be2f86573954f87e97f8a4dbb05cb0f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 32
|6 P:(DE-He78)fae1bf941c5fd76cf5356ecfa1243cc4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 33
|6 P:(DE-He78)551bb92841f634070997aa168d818492
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 34
|6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 35
|6 0000-0001-8287-5967
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 36
|6 P:(DE-He78)e13b4363c5fe858044ef8a39c02c870c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 37
|6 P:(DE-He78)509fb81813c1911954da583129e8ea57
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Cancer risk factors and prevention
|x 0
914 1 _ |y 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b LEUKEMIA : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b LEUKEMIA : 2015
920 1 _ |0 I:(DE-He78)B060-20160331
|k B060
|l B060 Molekulare Genetik
|x 0
920 1 _ |0 I:(DE-He78)G380-20160331
|k G380
|l KKE Neuropathologie
|x 1
920 1 _ |0 I:(DE-He78)G340-20160331
|k G340
|l KKE Pädiatrische Onkologie
|x 2
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l B062 Pädiatrische Neuroonkologie
|x 3
920 1 _ |0 I:(DE-He78)L101-20160331
|k L101
|l DKTK Heidelberg
|x 4
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B060-20160331
980 _ _ |a I:(DE-He78)G380-20160331
980 _ _ |a I:(DE-He78)G340-20160331
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a I:(DE-He78)L101-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21